August 11th 2025, 7:00pm
It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect real-world patient populations.
August 11th 2025, 5:14pm
The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are eligible for Hernexeos treatment.
August 11th 2025, 4:00pm
Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges of their myeloma diagnosis.
August 11th 2025, 3:00pm
August is World Cancer Support month, and a time to honor the quiet strength of caregivers and the communities that lift them up.
August 11th 2025, 1:00pm
Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.
August 10th 2025, 6:00pm
Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer, suggesting a possible role for preventative probiotics.
August 10th 2025, 2:00pm
Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according to Dr. Jacob Sands.
August 9th 2025, 6:00pm
Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.
August 9th 2025, 2:00pm
Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.
August 8th 2025, 9:00pm
Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid tumor, and urothelial cancers.
What Patients With Lung Cancer Need to Know About EGFR PACC Mutations
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome